Written by Charles Gumbley, BHSc (Clinical Nutrition), DipHSc (Western Herbal Medicine)
Last evidence check: 19 July 2026
This article is general education, not personalised medical advice. Fatty liver requires assessment of its cause and fibrosis risk. Ask a GP, pharmacist or liver specialist before starting or stopping a supplement, especially if you have diagnosed liver disease, diabetes, take medicines, are pregnant or breastfeeding, or drink alcohol regularly.
Key takeaways
- Current multidisciplinary guidance does not recommend nutraceuticals for metabolic dysfunction-associated steatotic liver disease (MASLD) because meaningful liver-outcome and safety evidence is insufficient.
- Liver enzymes, liver fat, inflammation and fibrosis are different outcomes.
- Vitamin E is a narrow specialist consideration for selected people, not a general retail recommendation.
- Milk thistle may change liver enzymes in some studies but has not shown meaningful histological benefit.
- Supplements and herbal products can themselves cause liver injury.
Conflict disclosure: Nutrition Market sells supplements. This guide does not rank or link products. Product feeds, category links and shop calls to action are disabled.
Best supplements for fatty liver: the guideline answer
The best supplements for fatty liver are not a ranked list. The 2024 EASL-EASD-EASO clinical guideline states that nutraceuticals cannot be recommended for adults with MASLD because evidence is insufficient for liver damage, fibrosis, liver-related outcomes and safety.¹
That answer is more cautious than many search results, but it reflects the outcomes that matter. A small fall in alanine aminotransferase (ALT) does not prove that scarring has improved. Reduced liver fat on imaging does not automatically show fewer future liver complications.
Scroll sideways to read the full table →
| Outcome | What it can tell us | What it cannot prove alone |
|---|---|---|
| ALT or AST | Possible change in liver-cell injury | Reversal of fibrosis |
| Ultrasound or MRI liver fat | Change in steatosis | Resolution of inflammation or scarring |
| Fibrosis test or elastography | Estimated scarring risk | The cause without clinical context |
| Biopsy | Tissue-level steatosis, inflammation and fibrosis | A supplement will improve long-term outcomes |
| Liver-related event | Decompensation, cancer, transplant or death | Usually requires long follow-up to study |
The genuine best supplements for fatty liver query remains in this title because readers ask it. The evidence-based answer may be no supplement until diagnosis, fibrosis risk, medicines, alcohol and metabolic health have been reviewed.
Some people don't need supplements for this purpose at all. Phrases such as support liver, improve liver health or support liver health are too broad to show that a product changes MASLD or a clinically important outcome.
Fatty liver disease is now called MASLD
Metabolic dysfunction-associated steatotic liver disease, or MASLD, is the current name for much of the condition previously called non-alcoholic fatty liver disease (NAFLD). Metabolic dysfunction-associated steatohepatitis, or MASH, replaces NASH when inflammation and liver-cell injury accompany fat accumulation.
The terminology change matters because fatty liver is not one diagnosis. Steatotic liver disease can also relate to alcohol, medicines, viral hepatitis, autoimmune disease, malnutrition or other causes. A scan that reports fat does not establish the cause or stage.
Many people have no obvious symptoms. Others may report fatigue or discomfort, but these do not measure fibrosis. Normal liver enzymes also do not reliably exclude advanced disease. A clinician may use history, blood tests and a non-invasive score such as FIB-4 before deciding whether elastography or specialist review is needed.¹
Seek urgent help for yellow skin or eyes, dark urine with pale stools, confusion, vomiting blood, black stools, severe or increasing abdominal swelling, fainting or marked drowsiness.
Liver fat and fibrosis are different outcomes
Liver fat is steatosis. Fibrosis is scar tissue formed after ongoing injury. MASH includes inflammation and hepatocyte injury, while cirrhosis describes advanced structural change. These stages are not interchangeable.
Fat accumulation in the liver can change without the same change in liver inflammation, liver cell damage or liver scarring. A study that appears to reduce liver fat must still be assessed for its method, population, duration and fibrosis findings.
Short supplement trials often measure enzymes, lipids, glucose or ultrasound grading because these outcomes are easier to collect. Those results may generate a research signal, but they cannot be promoted as proven fibrosis reversal or protection from liver cancer.
The 2024 guideline reviewed a Cochrane analysis covering 202 randomised trials of nutritional supplements. It found considerable uncertainty across clinical outcomes such as decompensation, liver cancer, transplantation, mortality and serious adverse events.¹
The guideline has a published erratum correcting the formula used for the enhanced liver fibrosis test on newer analysers.² It did not change the conclusion about nutraceuticals. Recording that distinction keeps a technical correction from being mistaken for a changed supplement recommendation.
Vitamin E and fatty liver disease
Vitamin E is not a general liver-health supplement for self-treatment. The 2023 AASLD guidance says it may be considered in selected people because it can improve MASH/NASH in some patients without diabetes. It also states that available evidence does not demonstrate an antifibrotic benefit and that it has not been carefully studied in cirrhosis.³
Vitamin E supplements sold to the public are not equivalent to specialist-directed vitamin E supplementation in a selected trial population. There is no single best dose for a retailer to recommend across fatty liver disease.
The dose studied in a major trial was high and used for a defined clinical population. It should not be copied into retail advice. Long-term high-dose vitamin E requires discussion of bleeding, medicine interactions and other potential risks.
Correcting a confirmed nutrient deficiency is a different decision from using vitamin E as disease therapy. A person with suspected or diagnosed liver disease should ask which outcome is being targeted, why they fit the studied population and how benefit and harm will be monitored.
Omega-3 fatty acids and liver health
Omega-3 fatty acids can lower triglycerides and may be used for severe hypertriglyceridaemia under appropriate care. That indication is different from claiming that fish oil is a treatment for MASLD or reverses liver fibrosis.
Trials have reported mixed changes in liver fat, enzymes and metabolic markers. Formulation, EPA and DHA amounts, baseline triglycerides, diet and study duration differ. A result for prescription-grade omega-3 also cannot be transferred automatically to every fish-oil capsule.
Fatty fish can form part of a dietary pattern, while fish oil supplements are concentrated products with different amounts and quality. Omega-3 fatty acids may be appropriate for a separate triglyceride indication without being MASLD therapy.
Discuss omega-3 with a clinician if you take anticoagulants or antiplatelet medicines, have a bleeding disorder, are preparing for surgery or use several products containing fish oil.
Milk thistle and liver function
Milk thistle contains a mixture commonly called silymarin. Some small studies and meta-analyses report lower ALT or AST, but the 2024 guideline notes that the few small randomised trials did not document histological improvement.¹ AASLD guidance says silymarin should not be used as NASH treatment because it does not offer meaningful histological benefit.³
This does not mean every enzyme result is false. It means a change in liver function tests is not enough to establish improved inflammation, fibrosis or long-term outcomes.
Products can also differ in extraction, standardisation, contaminants and actual silymarin exposure. Milk thistle should not delay fibrosis assessment, replace prescribed treatment or be combined with multiple liver detox formulas without an interaction review.
Supplements for fatty liver disease: evidence limits
Supplements for fatty liver disease include curcumin, probiotics, berberine, green tea extract, vitamin D, NAC, glutathione, artichoke, dandelion and multi-ingredient blends. Evidence is heterogeneous and often focuses on surrogate markers.
Certain vitamins and supplements can damage the liver, particularly when concentrated, contaminated, mislabelled or combined. Supplements for liver marketing should not be assumed safe for someone with chronic liver disease or another liver condition.
- Curcumin: formulation and bioavailability vary; enzyme changes do not prove fibrosis benefit.
- Probiotics: strain-specific findings cannot validate a generic probiotic category.
- Berberine: may interact with glucose-lowering and other medicines; pregnancy and breastfeeding require particular caution.
- Vitamin D: correct an identified deficiency for that health need, not as a guaranteed MASLD treatment.
- Green tea extract: concentrated extracts differ from drinking tea and have been associated with liver injury.
- NAC, glutathione, artichoke and dandelion: mechanistic or short-term evidence is not enough for a clinical recommendation.
- TUDCA and imported products: regulatory status, purity and interactions require careful review.
No ingredient result validates a proprietary blend. When a formula contains ten ingredients, it may be unclear which component caused benefit or harm.
Lifestyle changes for a healthy liver
Lifestyle changes are central to MASLD care, but they should be individualised and non-stigmatising. The guideline supports dietary quality, physical activity and reduction of sedentary time. Benefits can occur even before a large change in body weight.¹
Managing fatty liver means addressing the relevant causes and risks, not trying to support your liver with a cleanse. Healthy liver function and overall liver health are consumer phrases, not measurable claims on their own.
A practical plan may address sugary drinks, highly processed foods, fibre, protein, unsaturated fats, sleep, resistance and aerobic activity, smoking, alcohol and management of diabetes, blood pressure and lipids. A Mediterranean-style pattern is one option, not a compulsory branded diet.
If weight loss is appropriate and chosen, the goal and pace should be clinically suitable. Fastest and 14-day reversal promises ignore fibrosis, nutritional adequacy and individual risk. Coffee has observational associations with better liver outcomes, but this does not make a concentrated coffee extract a treatment.
Liver health and supplement-induced injury
Natural does not mean liver-safe. AASLD guidance recognises herbal and dietary supplements as a cause of liver injury and notes the difficulty of identifying the responsible ingredient in multi-component products.⁵
Supplements that claim to protect liver cells from damage may still cause an adverse reaction. Severe injury can lead to liver failure, which is why new symptoms and changed liver enzyme levels require assessment rather than a detox explanation.
Keep a list or photographs of every medicine, powder, tea, tincture, gummy and supplement. Record the brand, batch, amount and start date. If liver tests change, do not assume it is a harmless detox reaction.
Stop and seek prompt clinical advice for new jaundice, dark urine, severe itching, persistent nausea or vomiting, unusual fatigue or right-upper-abdominal pain after starting a product. Emergency symptoms include confusion, collapse, vomiting blood or black stools.
The Australian Liver Foundation advises people with liver disease not to start a liver tonic, medicine or supplement without discussing it with their doctor.⁴
Fatty liver FAQs
What is the best supplement to take for fatty liver?
No universal supplement is recommended by current MASLD guidance. Vitamin E is a narrow specialist consideration for selected people, while silymarin and other nutraceuticals lack sufficient meaningful outcome evidence.
What is the fastest way to reduce fatty liver?
There is no single fastest method suitable for everyone. Confirm the cause and fibrosis risk, then address diet, movement, alcohol, medicines and metabolic conditions with appropriate clinical support.
Can fatty liver be reduced in 14 days?
Short-term changes in liver fat or enzymes may occur, but a 14-day result cannot establish fibrosis reversal or long-term protection. Avoid crash diets and detox programmes.
How do you flush fat out of your liver?
The liver does not need a retail flush. Liver fat changes through metabolic processes over time. Detox language can distract from diagnosis, fibrosis assessment and sustained care.
Can vitamins and supplements make fatty liver worse?
Yes. Some herbal and dietary supplements can cause liver injury, interact with medicines or contain unexpected ingredients. Existing liver disease increases the importance of professional review.
Does milk thistle improve fatty liver?
Some studies report changes in liver enzymes, but current guidance does not find meaningful histological evidence and does not recommend silymarin as MASH/NASH treatment.
References
- European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity. EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease. Obesity Facts. 2024;17(4):374-444. doi:10.1159/000539371. PMC
- Erratum. Obesity Facts. 2024;17(6):658. doi:10.1159/000541386. PMC
- Rinella ME, et al. AASLD Practice Guidance on the Clinical Assessment and Management of Nonalcoholic Fatty Liver Disease. Hepatology. 2023;77(5):1797-1835. doi:10.1097/HEP.0000000000000323. PMC
- Liver Foundation. Liver Tonics. Liver Foundation Australia
- Fontana RJ, et al. AASLD Practice Guidance on Drug, Herbal, and Dietary Supplement-Induced Liver Injury. Hepatology. 2023;77(3):1036-1065. doi:10.1002/hep.32689. PMC
